Neuroimaging Evidence for Right Orbitofrontal Cortex Differences in Adolescents With Emotional and Behavioral Dysregulation.


Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
11 2019
Historique:
received: 28 06 2018
revised: 15 01 2019
accepted: 11 04 2019
pubmed: 21 4 2019
medline: 15 9 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

To characterize the structural and functional neurobiology of a large group of adolescents exhibiting a behaviorally and emotionally dysregulated phenotype. Adolescents aged 14 years from the IMAGEN study were investigated. Latent class analysis (LCA) on the Strengths and Difficulties Questionnaire (SDQ) was used to identify a class of individuals with elevated behavioral and emotional difficulties ("dysregulated"; n = 233) who were compared to a matched sample from a low symptom class (controls, n = 233). Whole-brain gray matter volume (GMV) images were compared using a general linear model with 10,000 random label permutations. Regional GMV findings were then probed for functional differences from three functional magnetic resonance imaging (fMRI) tasks. Significant brain features then informed mediation path models linking the likelihood of psychiatric disorders (DSM-IV) with dysregulation. Whole-brain differences were found in the right orbitofrontal cortex (R.OFC; p < .05; k = 48), with dysregulated individuals exhibiting lower GMV. The dysregulated group also exhibited higher activity in this region during successful inhibitory control (F A large sample of dysregulated adolescents exhibited lower GMV in the R.OFC relative to controls. Dysregulated individuals also exhibited higher regional activations when exercising inhibitory control at performance levels comparable to those of controls. These findings suggest a neurobiological marker of dysregulation and highlight the role of the R.OFC in impaired emotional and behavioral control.

Identifiants

pubmed: 31004740
pii: S0890-8567(19)30261-8
doi: 10.1016/j.jaac.2019.01.021
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1092-1103

Subventions

Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : P20 GM103644
Pays : United States
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH085772
Pays : United States
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States

Investigateurs

Tobias Banaschewski (T)
Gareth Barker (G)
Arun L W Bokde (ALW)
Uli Bromberg (U)
Christian Büchel (C)
Erin Burke Quinlan (EB)
Sylvane Desrivières (S)
Herta Flor (H)
Vincent Frouin (V)
Hugh Garavan (H)
Penny Gowland (P)
Andreas Heinz (A)
Bernd Ittermann (B)
Jean-Luc Martinot (JL)
Marie-Laure Paillère Martinot (ML)
Eric Artiges (E)
Herve Lemaitre (H)
Frauke Nees (F)
Dimitri Papadopoulos Orfanos (DP)
Tomáš Paus (T)
Luise Poustka (L)
Michael N Smolka (MN)
Nora C Vetter (NC)
Sarah Jurk (S)
Eva Mennigen (E)
Henrik Walter (H)
Robert Whelan (R)
Gunter Schumann (G)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Philip A Spechler (PA)

University of Vermont, Burlington; Vermont Center on Behavior and Health, University of Vermont, Burlington. Electronic address: philip.spechler@uvm.edu.

Bader Chaarani (B)

University of Vermont, Burlington; Vermont Center on Behavior and Health, University of Vermont, Burlington.

Catherine Orr (C)

University of Vermont, Burlington.

Scott Mackey (S)

University of Vermont, Burlington.

Stephen T Higgins (ST)

University of Vermont, Burlington; Vermont Center on Behavior and Health, University of Vermont, Burlington.

Tobias Banaschewski (T)

Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Arun L W Bokde (ALW)

School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland.

Uli Bromberg (U)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Christian Büchel (C)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Erin Burke Quinlan (EB)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Patricia J Conrod (PJ)

Universite de Montreal, CHU Ste Justine Hospital, Canada.

Sylvane Desrivières (S)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Herta Flor (H)

Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; School of Social Sciences, University of Mannheim, Mannheim, Germany.

Vincent Frouin (V)

NeuroSpin, CEA, Université Paris-Saclay, France.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, UK.

Andreas Heinz (A)

Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Germany.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud - University Paris Saclay, France.

Frauke Nees (F)

Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, France.

Luise Poustka (L)

University Medical Centre Göttingen, Germany, and the Clinic for Child and Adolescent Psychiatry, Medical University of Vienna, Austria.

Juliane H Fröhner (JH)

Technische Universität Dresden, Germany.

Michael N Smolka (MN)

Technische Universität Dresden, Germany.

Henrik Walter (H)

Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.

Gunter Schumann (G)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.

Hugh Garavan (H)

University of Vermont, Burlington; Vermont Center on Behavior and Health, University of Vermont, Burlington.

Robert R Althoff (RR)

University of Vermont, Burlington; Vermont Center on Behavior and Health, University of Vermont, Burlington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH